Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 39 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 7253341

    Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof

    Fulcrum SP Ltd. · Granted Aug 7, 2007 · Expires Aug 2, 2027

    granted
  2. US 7247751

    Processes for preparing cinacalcet hydrochloride crystal Form I

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 24, 2007 · Expires Jul 19, 2027

    granted
  3. US 7244844

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 17, 2007 · Expires Jul 12, 2027

    granted
  4. US 7235691

    Crystalline forms of modafinil

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 26, 2007 · Expires Jun 21, 2027

    granted
  5. US 7223424

    Compositions and methods for prostate and kidney health and disorders, an herbal preparation

    Integrated Chinese Medicine Holdings Ltd. · Granted May 29, 2007 · Expires May 24, 2027

    granted
  6. US 7195778

    Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 27, 2007 · Expires Mar 22, 2027

    granted
  7. US 7196222

    Sertraline hydrochloride form II and methods for the preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 27, 2007 · Expires Mar 22, 2027

    granted
  8. US 7192588

    Vaccine composition and method of using the same

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 20, 2007 · Expires Mar 15, 2027

    granted
  9. US 7189861

    Processes for preparing amorphous atorvastatin hemi-calcium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 13, 2007 · Expires Mar 8, 2027

    granted
  10. US 7189706

    C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing them

    CAN-FITE BIOPHARMA LTD. · Granted Mar 13, 2007 · Expires Mar 8, 2027

    granted
  11. US 7183272

    Crystal forms of oxcarbazepine and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 27, 2007 · Expires Feb 22, 2027

    granted
  12. US 7173062

    Method for the improvement of skin wrinkles using retinyl retinoate

    ENPRANI CO., LTD. · Granted Feb 6, 2007 · Expires Feb 1, 2027

    granted
  13. US 7161012

    Processes for preparing amorphous atorvastatin hemi-calcium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 9, 2007 · Expires Jan 4, 2027

    granted
  14. US 7151183

    Processes for preparing amorphous atorvastatin hemi-calcium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 19, 2006 · Expires Dec 14, 2026

    granted
  15. US 7148376

    Polymorphic forms of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 12, 2006 · Expires Dec 7, 2026

    granted
  16. US 7144916

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 5, 2006 · Expires Nov 30, 2026

    granted
  17. US 7144720

    Protein and DNA thereof

    Takeda Chemical Industries Ltd. · Granted Dec 5, 2006 · Expires Nov 30, 2026

    granted
  18. US 7141553

    A3AR agonists for the treatment of inflammatory arthritis

    Can-Fite Biopharma Ltd. Israel · Granted Nov 28, 2006 · Expires Nov 23, 2026

    granted
  19. US 7138137

    Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 21, 2006 · Expires Nov 16, 2026

    granted
  20. US 7129358

    Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 31, 2006 · Expires Oct 26, 2026

    granted
  21. US 7126008

    Carvedilol

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 24, 2006 · Expires Oct 19, 2026

    granted
  22. US 7122681

    Desolvation process for the production of atorvastatin hemi-calcium essentially free of bound organic solvent

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted
  23. US 7112574

    C2,8-disubstituted adenosine derivatives and their different uses

    CAN-FITE BIOPHARMA LTD. · Granted Sep 26, 2006 · Expires Sep 21, 2026

    granted
  24. US 7098364

    Phenylethanolamine compounds as β2-receptor agonists, and methods of use and preparation thereof

    Jinzhou Jiutai Pharmaceutical Co., Ltd., China · Granted Aug 29, 2006 · Expires Aug 24, 2026

    granted